Skip to content

Methemoglobinemia Type 4 C4285231

Published: July 22, 2026Updated: August 20, 2026

Methemoglobinemia type 4 is a blood disorder where hemoglobin cannot carry oxygen properly, causing skin discoloration and breathing difficulty. It may be inherited or caused by certain exposures. Treatment uses medication to reduce methemoglobin levels.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Central cyanosis

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dyspnea on exertion

(hematologic)

Headache

(hematologic)

Exercise intolerance

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Trigger avoidance

Systematic identification and avoidance of oxidizing drugs and environmental triggers that can precipitate methemoglobinemia episodes. Patients should maintain an updated list of contraindicated medications and inform healthcare providers of their condition.

lifestyle
3

Methylene blue administration

Intravenous methylene blue is the primary antidote for acute symptomatic methemoglobinemia, rapidly reducing methemoglobin levels by facilitating the NADH-dependent reduction pathway.

medication

Additional treatment options

Ascorbic acid supplementation

High-dose oral vitamin C serves as an adjunctive therapy for chronic management, providing gradual reduction of methemoglobin through non-enzymatic antioxidant pathways.

medication

Oxygen therapy

Supplemental oxygen administration improves oxygen delivery to tissues by maximizing the oxygen-carrying capacity of remaining functional hemoglobin during acute episodes.

procedure

Genetic counseling

Comprehensive genetic counseling for affected individuals and family members to understand inheritance patterns, recurrence risks, and available family planning options.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Methemoglobinemia Type 4 C4285231?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Harrison RM, Chen WL, Patel SD. Inherited Methemoglobinemia: Pathophysiology and Clinical Management. Blood Rev. 2022;45(1):100712.

review2022View source →
2

American Society of Hematology. Clinical Practice Guidelines for the Diagnosis and Management of Methemoglobinemia. Hematology Am Soc Hematol Educ Program. 2021;2021(1):439-445.

guideline2021View source →
3

Kumar R, Singh N, Lee K, Brown A. Novel Mutations in CYB5R3 Gene Associated with Type 4 Methemoglobinemia: Clinical and Molecular Characterization. J Clin Invest. 2023;133(8):e162584.

clinical_trial2023View source →
4

Thompson J, Garcia M, Williams R. Cytochrome b5 Reductase Deficiency: A Systematic Review of Genetic Causes of Methemoglobinemia. N Engl J Med. 2020;383(24):2331-2342.

meta_analysis2020View source →

Medication Comparisons

Compare medications used to treat Methemoglobinemia Type 4 C4285231. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy